Prooksa Ananchuensook

Bangkok, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Multi-kingdom signatures of the gut microbiome in Lynch syndrome: a prospective model for colorectal cancer evolution.

Multi-kingdom signatures of the gut microbiome in Lynch syndrome: a prospective model for colorectal cancer evolution.

Journal: Gut

Published: April 10, 2026

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 01, 2025

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-Associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-Associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 01, 2025

Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 01, 2025

Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study.

Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study.

Journal: Hepatology (Baltimore, Md.)

Published: August 21, 2025

Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study.

Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study.

Journal: Hepatology (Baltimore, Md.)

Published: August 21, 2025

Efficacy and safety of Atezolizumab plus Bevacizumab and Lenvatinib as first-line systemic therapies for hepatocellular carcinoma: A real-world study.

Efficacy and safety of Atezolizumab plus Bevacizumab and Lenvatinib as first-line systemic therapies for hepatocellular carcinoma: A real-world study.

Journal: PloS one

Published: August 17, 2025

Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study.

Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study.

Journal: Hepatology (Baltimore, Md.)

Published: July 11, 2025

Machine learning models for predicting hepatocellular carcinoma development in patients with chronic viral hepatitis B infection.

Machine learning models for predicting hepatocellular carcinoma development in patients with chronic viral hepatitis B infection.

Journal: Asian biomedicine : research, reviews and news

Published: April 15, 2025

Combination of modified albumin-bilirubin grade and platelet count to predict high-risk varices in patients with hepatocellular carcinoma.

Combination of modified albumin-bilirubin grade and platelet count to predict high-risk varices in patients with hepatocellular carcinoma.

Journal: PloS one

Published: February 28, 2025

Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis.

Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis.

Journal: Thrombosis and haemostasis

Published: January 09, 2025

Diagnostic Performance of Serum Mac-2-Binding Protein Glycosylation Isomer as a Fibrosis Biomarker in Non-Obese and Obese Patients with MASLD.

Diagnostic Performance of Serum Mac-2-Binding Protein Glycosylation Isomer as a Fibrosis Biomarker in Non-Obese and Obese Patients with MASLD.

Journal: Biomedicines

Published: December 22, 2024

Showing 1-12 of 27

Last Updated: 09/26/2026